These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12227881)

  • 21. Estrogen and estrogen-progestogen replacement: therapy and cardiovascular diseases.
    Barrett-Connor E
    Am J Med; 1993 Nov; 95(5A):40S-43S. PubMed ID: 8256794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.
    Dubey RK; Imthurn B; Barton M; Jackson EK
    Cardiovasc Res; 2005 May; 66(2):295-306. PubMed ID: 15820198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unanswered questions in hormonal replacement therapy.
    Rebar RW
    Exp Gerontol; 1994; 29(3-4):447-61. PubMed ID: 7925763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oestrogens and the heart.
    Rosano GM; Panina G
    Therapie; 1999; 54(3):381-5. PubMed ID: 10500455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women.
    Dallongeville J; Marecaux N; Isorez D; Zylbergberg G; Fruchart JC; Amouyel P
    Atherosclerosis; 1995 Nov; 118(1):123-33. PubMed ID: 8579622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogens, progestins and lipid metabolism.
    Tikkanen MJ
    Maturitas; 1996 May; 23 Suppl():S51-5. PubMed ID: 8865140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women.
    Seed M; Sands RH; McLaren M; Kirk G; Darko D
    Fam Pract; 2000 Dec; 17(6):497-507. PubMed ID: 11120722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical profiles of progestins used in formulations of oral contraceptives and hormone replacement therapy.
    Hammond GL; Rabe T; Wagner JD
    Am J Obstet Gynecol; 2001 Aug; 185(2 Suppl):S24-31. PubMed ID: 11521119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen and cardiovascular function after menopause.
    Samaan SA; Crawford MH
    J Am Coll Cardiol; 1995 Nov; 26(6):1403-10. PubMed ID: 7594062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hormone substitution in the menopause: effect on lipids and cardiovascular risk].
    Keller U
    Schweiz Rundsch Med Prax; 1991 Apr; 80(16):413-7. PubMed ID: 2038637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HRT to prevent cardiovascular disease. What studies show, how to advise patients.
    Wood MJ; Cox JL
    Postgrad Med; 2000 Sep; 108(3):59-60, 63-6, 69-72. PubMed ID: 11004936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical aspects of estrogen and the cardiovascular system.
    Sullivan JM; Fowlkes LP
    Obstet Gynecol; 1996 Feb; 87(2 Suppl):36S-43S. PubMed ID: 8559552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HT and CVD prevention. from myth to reality.
    Wenger NK
    Fertil Steril; 2003 Oct; 80 Suppl 4():10-4; quiz 54-5. PubMed ID: 14568282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hormone substitution in menopause].
    Keller PJ; Maurer-Major E
    Praxis (Bern 1994); 1997 Sep; 86(38):1458-62. PubMed ID: 9381046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hormone replacement therapy and endometrial cancer].
    Concin H; Sommerlechner M
    Gynakol Geburtshilfliche Rundsch; 1998; 38(2):93-5. PubMed ID: 9815525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menopause and hormone replacement therapy: the 2017 Recommendations of the Italian Menopause Society.
    Gambacciani M; Biglia N; Cagnacci A; Caruso S; Cicinelli E; DE Leo V; DI Carlo C; Farris M; Gambera A; Guaschino S; Lanzone A; Paoletti AM; Russo N; Vicariotto F; Villa P; Volpe A;
    Minerva Ginecol; 2018 Feb; 70(1):27-34. PubMed ID: 28975776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular implications of estrogen replacement therapy.
    Lobo RA
    Obstet Gynecol; 1990 Apr; 75(4 Suppl):18S-25S; discussion 31S-35S. PubMed ID: 2179786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone replacement therapy. Protection against the consequences of menopause.
    Marshburn PB; Carr BR
    Postgrad Med; 1992 Sep; 92(4):145-8, 151-2, 157-9. PubMed ID: 1528813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogens, progestins and breast cancer risk in post-menopausal women: state of the ongoing controversy in 1992.
    Sitruk-Ware R
    Maturitas; 1992 Oct; 15(2):129-39. PubMed ID: 1470045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen replacement therapy (ERT) and hormone replacement therapy (HRT) in the prevention of cardiovascular diseases.
    Nikolov R; Golbs S; Schneider HP
    Zentralbl Gynakol; 1999; 121(2):101-4. PubMed ID: 10096179
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.